×
About 710 results

ALLMedicine™ Pulmonary Alveolar Proteinosis Center

Research & Reviews  255 results

Natural History Study of GATA2 Deficiency and Related Disorders
https://clinicaltrials.gov/ct2/show/NCT01905826

Jun 24th, 2022 - Mutations in GATA2, a critical hematopoietic transcription factor, underlie a complex congenital disorder characterized by immunodeficiency, bone marrow failure, and lymphatic/vascular dysfunction. Patients with GATA2 deficiency may suffer from a ...

Rituximab for Anti-cytokine Autoantibody-Associated Diseases
https://clinicaltrials.gov/ct2/show/NCT01842386

Jun 24th, 2022 - Anticytokine autoantibodies are an important and emerging cause of disease. Anticytokine autoantibody-associated diseases include disseminated nontuberculous mycobacterial infection caused by anti-interferon- >= autoantibodies, severe mucocutaneou...

Comparison of Procedural Yield of Bronchoalveolar Lavage Using Three Different Techniques in Subjects Undergoing Flexible Bronchoscopy
https://clinicaltrials.gov/ct2/show/NCT05425875

Jun 22nd, 2022 - Bronchoalveolar lavage (BAL) via flexible bronchoscopy is a method used to sample the cellular and microbiological components of the alveolar space. It is a procedure in which 2-3 measured aliquots of sterile normal saline are instilled after wedg...

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
https://clinicaltrials.gov/ct2/show/NCT04544293

Jun 21st, 2022 - This is an interventional, randomized, double-blind, 2-arm, parallel groups, placebo-controlled, multi-center, phase 3 trial in adult subjects who are diagnosed with aPAP. An aPAP diagnosis should be confirmed by an anti-GM-CSF auto-antibody test ...

Single lung transplantation for idiopathic pulmonary alveolar proteinosis with intraope...
https://doi.org/10.1016/j.trim.2022.101627
Transplant Immunology; Liang J, Chen Y et. al.

May 15th, 2022 - Pulmonary alveolar proteinosis (PAP) is a rarely progressive disease. This disease is characterized by the accumulation of a large amount of pulmonary surfactant in the alveolar cavity and terminal bronchiole, which is caused by the obstruction of...

see more →

Clinicaltrials.gov  23 results

Natural History Study of GATA2 Deficiency and Related Disorders
https://clinicaltrials.gov/ct2/show/NCT01905826

Jun 24th, 2022 - Mutations in GATA2, a critical hematopoietic transcription factor, underlie a complex congenital disorder characterized by immunodeficiency, bone marrow failure, and lymphatic/vascular dysfunction. Patients with GATA2 deficiency may suffer from a ...

Rituximab for Anti-cytokine Autoantibody-Associated Diseases
https://clinicaltrials.gov/ct2/show/NCT01842386

Jun 24th, 2022 - Anticytokine autoantibodies are an important and emerging cause of disease. Anticytokine autoantibody-associated diseases include disseminated nontuberculous mycobacterial infection caused by anti-interferon- >= autoantibodies, severe mucocutaneou...

Comparison of Procedural Yield of Bronchoalveolar Lavage Using Three Different Techniques in Subjects Undergoing Flexible Bronchoscopy
https://clinicaltrials.gov/ct2/show/NCT05425875

Jun 22nd, 2022 - Bronchoalveolar lavage (BAL) via flexible bronchoscopy is a method used to sample the cellular and microbiological components of the alveolar space. It is a procedure in which 2-3 measured aliquots of sterile normal saline are instilled after wedg...

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
https://clinicaltrials.gov/ct2/show/NCT04544293

Jun 21st, 2022 - This is an interventional, randomized, double-blind, 2-arm, parallel groups, placebo-controlled, multi-center, phase 3 trial in adult subjects who are diagnosed with aPAP. An aPAP diagnosis should be confirmed by an anti-GM-CSF auto-antibody test ...

Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
https://clinicaltrials.gov/ct2/show/NCT02702180

Apr 15th, 2022 - The trial is a phase 2, randomized, double-blind, placebo-controlled multicentre clinical trial investigating efficacy and safety of inhaled molgramostim (rhGM-CSF) in patients with aPAP. The trial will include 2 periods; a double-blind treatment ...

see more →

News  6 results

Winners: Abstract Awards
https://www.mdedge.com/chestphysician/article/214601/society-news/winners-abstract-awards

Jan 17th, 2020 - Alfred Soffer Research Award Winners Johnathan Chung: EVALUATING CLINICAL UTILITY OF A UIP GENOMIC CLASSIFIER IN SUBJECTS WITH AND WITHOUT A HRCT PATTERN OF UIP Girish Nair, MD: QUANTITATIVE LUNG FUNCTION IMAGING USING NOVEL INTEGRATED JACOBIAN VE.

Lethal Lung Disease and Biologics: Is There a Link?
https://www.medpagetoday.com/rheumatology/arthritis/81966

Sep 4th, 2019 - A new, potentially life-threatening parenchymal lung disease is increasingly being detected in patients with systemic juvenile idiopathic arthritis (sJIA), according to recent reports. Systemic JIA is distinct from other forms of JIA in that the a...

Targeting GM-CSF Works in Rheumatoid Arthritis, Phase II Study Confirms
https://www.medpagetoday.com/rheumatology/arthritis/79408

Apr 24th, 2019 - Namilumab, a monoclonal antibody that targets the granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand, showed promise as a treatment for rheumatoid arthritis (RA) in a phase II study. At week 12, patients showed good improvement in di...

Rheuminations: New RA Antibody Coming Soon?
https://www.medpagetoday.com/rheumatology/arthritis/44404

Feb 20th, 2014 - Patients with rheumatoid arthritis (RA) who don't do well with the available biologic therapies may soon have another therapeutic option: monoclonal antibodies that target granulocyte-macrophage colony-stimulating factor (GM-CSF). This molecule, o...

Pulmonary Opacities in a Patient With Essential Thrombocythemia
https://www.medscape.com/viewarticle/405329_2

Nov 27th, 2001 - Discussion Since the HRCT findings in this case were not typical for nontuberculous mycobacterial pulmonary infection, the patient underwent thoracoscopic lung biopsy, which provided the diagnosis of pulmonary alveolar proteinosis (PAP). Due to th...

see more →